The Illinois Research and Development Tax Credit and Pass-Through Entities: Compliance, Allocation, and Strategic Utilization

I. Executive Summary: The Illinois R&D Credit and Pass-Through Entities

The Illinois R&D tax credit (IITA § 201(k)) provides a non-refundable tax reduction equal to 6.5% of the increase in qualified research expenditures performed within the state. For Partnerships, S Corporations, and Limited Liability Companies, this non-refundable credit is computed at the entity level but is mandatory for allocation to the individual owners, who claim it against their personal Illinois income tax liability.

The Illinois Research and Development (R&D) credit is a vital incentive established under the Illinois Income Tax Act (IITA) Section 201(k), designed to stimulate economic growth through in-state innovation.1 This credit was recently extended by Public Act 103-0595, ensuring its availability for tax years ending on or before December 31, 2031.2 Due to their classification as non-taxable conduits under the primary income tax structure, Pass-Through Entities (PTEs) cannot utilize the credit directly. Instead, the statute mandates a rigorous flow-through structure where the credit is calculated by the entity, reported on Illinois Schedule 1299-A, and then precisely distributed to the respective partners, shareholders, or members based on their distributive share of income. These individuals subsequently claim the credit on their personal or corporate Illinois tax returns using Schedule 1299-C or 1299-D.2 Effective credit utilization necessitates not only meticulous compliance with the federal Qualified Research Expenditure (QRE) definitions (IRC § 41) but also strict adherence to unique Illinois sourcing rules, base period calculation methodologies, and the five-year limitation on carrying forward any unused credit.3

II. Definitional and Legislative Framework for Pass-Through Entities

A. Legal Status of Pass-Through Entities (PTEs) under Illinois Income Tax Law

1. Statutory Definition of PTEs

Under the Illinois Income Tax Act, an entity is defined as a “Pass-through entity” if it is exempt from the corporate income tax under subsection (b) or (c) of Section 205.5 The Illinois Department of Revenue (IDOR) clarifies in its publications that a PTE includes any partnership, S corporation, or fiduciary.6 This foundational classification confirms that these entities are viewed as conduits for the primary taxation of income and credits derived from business operations within the state.

2. Treatment of Limited Liability Companies (LLCs)

While the statutory definitions sometimes list only partnerships and S corporations, Limited Liability Companies (LLCs) are universally included in the context of the R&D credit based on their election of federal tax classification.7 If an LLC elects to be taxed as a partnership (multi-member) or as an S corporation, it must adhere to the PTE credit flow-through rules. If an LLC is a single-member disregarded entity for federal purposes, the activities and corresponding QREs flow directly to the sole owner, who then claims the credit as an individual taxpayer, bypassing the K-1-P distribution process.

3. The R&D Credit vs. Elective PTE Tax

A key complexity arises from the relatively new elective Pass-Through Entity (PTE) tax. Partnerships and S corporations may elect to pay the state income tax at the entity level (currently 4.95%).8 This election, enacted as a mechanism to help owners work around the federal $10,000 limitation on the State and Local Tax (SALT) deduction, has created an entity-level liability for income tax that is then credited back to the owners.8

However, the election to pay the PTE tax does not alter the fundamental mechanism of the R&D tax credit. The R&D credit is specifically claimed against the tax imposed by IITA subsections (a) and (b) 1, which relates to the individual income tax liability. Therefore, even if the entity elects to pay the PTE tax on Form IL-1065 or IL-1120-ST, the non-refundable R&D credit must still be calculated at the entity level and then passed through to the partners or shareholders via Schedule K-1-P.2 The credit remains an owner-level incentive designed to offset the owner’s resulting personal tax obligation, providing a critical distinction from the general PTE tax mechanism.

B. Statutory Authority and Duration of the R&D Credit

The Illinois R&D credit is a non-refundable credit provided under IITA § 201(k).1 The credit rate is fixed at 6.5% of the qualifying expenditures for increasing research activities in Illinois.3 The non-refundable nature is a primary constraint; it can only reduce an owner’s tax liability to zero, but it cannot generate a cash refund.3 Unused credits resulting from this limitation may be carried forward for a maximum of five years.4 This relatively short carryforward period necessitates active planning by both the PTE and its owners to ensure the benefit is fully realized before the credit expires. The statutory authorization for this credit was recently extended through tax years ending on or before December 31, 2031.1

III. Qualified Research Expenditure (QRE) Requirements and Sourcing for PTEs

A. Alignment with Federal Standards (IRC § 41)

Illinois aligns its definition of Qualified Research Expenditures (QREs) and qualified research activity closely with the federal standards established under Internal Revenue Code (IRC) Section 41.3 For research activity to qualify, it must meet the four-part test defined by the IRS: the activity must be related to developing or improving the functionality or quality of a business component, involve technological advancement, incorporate technical uncertainty, and rely on an experimental process.14

Eligible QRE categories include:

1. Wages: Salaries paid to employees performing, directly supervising, or directly supporting qualified research.2
2. Supplies: The cost of tangible property consumed in the research process, such as materials used for prototypes.2
3. Computer Costs: Rental or lease costs of computers used directly in the research.3
4. Contract Research Expenses: 65% of amounts paid to third-party contractors for conducting qualified research services.2

B. The Critical Sourcing Rule: Attributability to Illinois Activity

The most significant state-specific requirement for PTEs, especially those operating across state lines, is the mandatory sourcing rule: expenditures must be “attributable to research in Illinois”.10 This mandate requires the PTE to meticulously separate QREs incurred within Illinois from those incurred elsewhere.

For multi-state PTEs, this localized sourcing of QREs represents a principal area of compliance risk. The entity must maintain detailed records that support the geographic attribution of expenses, such as employee time tracking sheets showing hours spent conducting research activities within Illinois versus other states.3 Failure to demonstrate that the underlying research activities took place within the state’s boundaries, regardless of where the entity’s headquarters are located, can lead to the disallowance of the credit upon audit by the IDOR. This emphasis on rigorous Illinois-specific documentation ensures that the state incentive benefits only those activities intended to spur local economic development.

C. Non-Qualifying Activities

In line with federal law, Illinois specifically prohibits claiming the R&D credit for certain types of activities, including research conducted after the start of commercial production, adaptation of an existing product for a specific customer, market research, or research funded by another party or a government entity.10 Tax professionals must confirm that the PTE’s activities meet the definition of qualified research and do not fall into these statutory exclusion categories, thereby reducing the probability of audit adjustments that could cascade down to the individual owners’ tax liabilities.

IV. Detailed Incremental Calculation Methodology and Base Period Analysis

The calculation of the Illinois R&D tax credit is based on the Alternative Simplified Method (ASM) model, which measures the increase in current QREs over an average base period.4 This method is conducted exclusively at the PTE level.

A. Formula and Structure

The core calculation requires the PTE to use the Research and Development Worksheet provided within the instructions for Schedule 1299-I.2

The credit is calculated as:

$$\text{Credit} = 6.5\% \times (\text{Current Year Illinois QREs} – \text{Base Amount})$$

3

The base amount is crucial, as the credit is only generated by expenditures that represent an increase in research activity. If current QREs do not exceed the historical average, no credit is available.10

B. Base Period Calculation Rules

1. Three-Year Lookback

The Base Amount is defined as the yearly average of Illinois qualifying expenditures incurred during the three taxable years immediately preceding the current taxable year.13 This historical average serves as the benchmark for determining incremental activity.4

2. Treatment of Startup Years and Zero QREs

For PTEs that are relatively new or those that did not incur QREs in certain prior years, the Illinois regulation provides clear guidance: if the taxpayer incurred no qualifying expenditures during a base period year, the qualifying expenditures for that year are zero.12 This is highly beneficial for startup entities, as a zero-base period year lowers the overall average, making it easier to demonstrate an increase in QREs and thus generate a larger credit amount.3 Furthermore, QREs incurred in years when the credit was not available (such as during the temporary suspension period ending in 2004) must still be included in the base period computation.12

3. Base Period Annualization Requirement

The Illinois Administrative Code (86 Ill. Admin. Code 100.2160(c)(3)) imposes a critical complexity for PTEs that began business or operations mid-year during any base period year. If the taxpayer was “doing business in this State for only part of a base period year,” the QREs for that year must be annualized.12

The required annualization formula is:

$$\text{Annualized QREs} = \frac{\text{Qualified Expenditures} \times 365}{\text{Number of days doing business in Illinois}}$$

2

The application of this rule can significantly impact the calculation. For instance, a PTE starting business on July 1 (184 days) with $\$500,000$ in QREs would be forced to use an annualized QRE amount of approximately $\$994,565$ for that base period year. This administrative requirement artificially inflates the base period average, requiring the PTE to incur substantially higher QREs in the current year to exceed the elevated benchmark and generate any credit. This provision effectively diminishes the immediate R&D credit benefit for businesses with non-standard base period operational timelines in Illinois.

V. IDOR Regulatory Guidance and Allocation for Pass-Through Entities

A. The Mandatory Flow-Through and Allocation Basis

Because PTEs are exempt from the standard corporate income tax imposed by IITA Section 201(a) and (b), they are legally prohibited from claiming the R&D credit themselves.5 Instead, the non-refundable credit is required to flow through to the owners.3 The allocation must be based on the owner’s distributive share of the entity’s income.16

For partnerships, the IITA explicitly refers to the federal allocation rules, stating that credits “shall be allocated among the partners in the partnership in accordance with the rules set forth in Section 704(b) of the Internal Revenue Code”.1

B. Strategic Implications of IRC § 704(b) Reference

The explicit reference to IRC § 704(b) in the Illinois statute concerning partnership allocation is of high strategic importance. Since Section 704(b) governs whether a partner’s distributive share has “substantial economic effect,” this reference implies that partnerships may have the flexibility to specially allocate the R&D credit among partners, provided such special allocation is respected for federal tax purposes.

Given that the Illinois R&D credit is non-refundable and subject to a five-year carryforward limit 4, strategic allocation becomes a powerful tool. A special allocation agreement could direct a disproportionate share of the R&D credit to a partner with a substantial Illinois personal income tax liability. This action maximizes the probability that the credit will be utilized immediately, rather than expiring due to the owner’s insufficient liability or the inability to consume the credit within the five-year carryforward window. This necessitates thorough review of the partnership or operating agreement to ensure compliance with federal and state regulations.

C. IDOR Reporting Pathway and Required Forms

The allocation and claiming process involves a three-step filing sequence, governed by IDOR forms:

1. Entity-Level Computation (Schedule 1299-A)

The PTE (filing Form IL-1065 for partnerships or IL-1120-ST for S corporations) is responsible for calculating the total available R&D credit (Credit Code 5340) on Schedule 1299-A, Income Tax Credits.2 This schedule incorporates the results of the complex incremental calculation derived from the Research and Development Worksheet.

2. Distribution Document (Schedule K-1-P)

Once the total credit is determined, the PTE must issue a separate Schedule K-1-P, Partner’s or Shareholder’s Share of Income, Deductions, Credits, and Recapture, to each owner.17 The K-1-P reports the precise distributive share of the R&D credit allocated to that specific owner. The allocated credit is reported on the line designated for Illinois income tax credits, calculated by multiplying the total credit from Schedule 1299-A by the partner’s share percentage.18

3. Owner-Level Claiming (Schedule 1299-C or 1299-D)

The owner receiving the K-1-P claims the credit against their own Illinois income tax liability. Individual owners utilize Schedule 1299-C 3, entering the amount received from the PTE into Column F, titled “Distributive Share Credit from K-1-P”.2 Corporate partners or fiduciaries use Schedule 1299-D.3 For the credit to be validly claimed, the tax year ending on the Schedule K-1-P must fall within the owner’s own tax year.2

The following table summarizes the compliance pathway:

R&D Credit Flow-Through and Reporting Requirements

VI. Comprehensive Case Study: An S Corporation’s R&D Credit Calculation and Allocation

This case study illustrates the required incremental calculation and the resulting flow-through to owners of a Pass-Through Entity.

A. Scenario: Innovate Corp, S Corporation

Innovate Corp is an Illinois S corporation that began R&D activities on January 1 of Year 1. It calculates its credit for Year 4. The ownership is split between Shareholder A (60% ownership) and Shareholder B (40% ownership).

B. Illinois QRE Data and Base Period Calculation

All expenditures are sourced exclusively to research activities performed within Illinois. Since the entity operated for the full year in all base periods, no annualization is necessary.

Illinois QRE Data and Base Calculation

C. Credit Calculation (Schedule 1299-A)

1. Current Year Illinois QREs (Year 4): $\$900,000$
2. Base Amount (Average Y1-Y3): $\$500,000$
3. Incremental QREs: $\$900,000 – \$500,000 = \mathbf{\$400,000}$
4. Final R&D Credit (6.5%): $\$400,000 \times 0.065 = \mathbf{\$26,000}$ (Total Credit Code 5340)

D. Allocation to Shareholders (Schedule K-1-P Distribution)

Innovate Corp allocates the full $\$26,000$ non-refundable credit to its shareholders based on their pro-rata ownership share, reflecting their distributive share of income:

Shareholder R&D Credit Allocation

E. Utilization and Carryforward Constraint

If Shareholder B has an Illinois tax liability of only $\$8,000$ in Year 4, this shareholder is limited to using $\$8,000$ of the allocated credit immediately. The remaining amount of $\$2,400$ $(\$10,400 – \$8,000)$ becomes an unused, non-refundable credit. Shareholder B may carry this unused portion forward for up to five years. This demonstrates that while the PTE successfully calculated and allocated the credit, the non-refundable nature of the credit and the owner’s personal tax situation dictate the ultimate value and timing of the tax benefit.4

VII. Compliance Risks, Documentation, and Best Practices for PTEs

A. Audit Preparedness and Documentation

For any taxpayer claiming the R&D credit, audit readiness is paramount, though claiming the credit itself does not automatically trigger an audit.20 Given the flow-through mechanism, audit deficiencies found at the PTE level will directly affect the tax returns of every partner or shareholder.

Thorough documentation is the first line of defense against IDOR scrutiny.15 This documentation must substantiate two key areas: the eligibility of the activities and the sourcing of the expenditures. PTEs must maintain records confirming that the activities meet the federal four-part test and detailed expense ledgers for QREs, focusing on time tracking logs, payroll data, and vendor invoices that tie employee wages and supply costs directly to qualified research tasks.14

B. Critical Compliance Issues Identified by IDOR

IDOR auditors have noted recurring compliance failures related to the complexity of the calculation and the sourcing rules.21

1. Improper Base Calculation: A frequent error is the failure to accurately compute the three-year base average. This includes overlooking the requirement to use a zero factor for years where no QREs were incurred 12, or, conversely, failing to include QREs from base years during which the credit itself was suspended.12 Most significantly, auditors look for compliance with the annualization rule (86 Ill. Admin. Code 100.2160), where QREs for partial base years must be artificially inflated. Incorrect application of this annualization rule, which can suppress the current year’s incremental credit, is a frequent point of contention.2
2. Inadequate Illinois Sourcing: For multi-state PTEs, auditors focus intensely on whether the QREs claimed on the Schedule 1299-A are genuinely tied to research activities performed physically within Illinois.3 Generalized cost allocations without specific, contemporaneous records (such as geo-located time logs or equipment usage reports) are highly vulnerable to disallowance.
3. K-1-P Allocation Errors: Mismatches in the distributive share percentage used for the R&D credit flow-through on Schedule K-1-P, or failure to issue the necessary K-1-P documentation to owners, can result in the disallowance of the credit at the individual level.2

C. Strategic Recommendations for Maximizing the R&D Incentive

Maximizing the value of the Illinois R&D credit for PTE owners requires a comprehensive, proactive strategy:

1. Prioritize Base Period Accuracy: The PTE must implement a robust system to track Illinois-only QREs for at least four concurrent years (current year plus three base years). Specialized tax expertise is necessary to ensure the complex annualization rules are applied correctly, thereby establishing a defensible base amount.3
2. Optimize Credit Utilization: Because of the non-refundable status and the five-year carryforward limit 3, the PTE and its owners should coordinate tax planning. For partnerships, careful legal structuring of the operating agreement, leveraging the explicit reference to IRC § 704(b) 1, can allow for strategic special allocations of the credit to partners with sufficient Illinois tax liability, thereby preventing the credit from expiring unused.
3. Maintain Compliance Synchronization: An annual compliance review should confirm synchronization between the entity’s calculation on Schedule 1299-A and the distributive amounts reported on all Schedules K-1-P. This review should also confirm that the tax years align between the PTE and the recipients, as required by IDOR guidance.2

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/